Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|23|3298-3305

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.23, 2015-01, pp. : 3298-3305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder

By  

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3306-3310

Bentham Science Publishers

Access to resources Recommend Favorite

Unlicensed and off-label drug use in children: implications for safety

By Choonara Imti  

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 81-83

Informa Healthcare

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use in Children: Implications for Safety

By Choonara I.   Conroy S.  

Drug Safety, Vol. 25, Iss. 1, 2002-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Off-label uses of trazodone: a review

By Bossini Letizia   Casolaro Ilaria   Koukouna Despoina   Cecchini Federica   Fagiolini Andrea  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1707-1717

Informa Healthcare

Access to resources Recommend Favorite

Antibiotic Use in Children - Off-Label Use

By  

Current Drug Targets, Vol. 13, Iss. 7, 2012-06 ,pp. : 885-892

Bentham Science Publishers

Access to resources Recommend Favorite